Cargando…

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide. PAFAH1B3 plays an important role on occurrence and development in a variety tumor. However, the function of PAFAH1B3 in HCC remains unclear. METHODS: The TIMER, ONCOMINE, Human Protein Atlas (H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Weikang, Lu, Xinyu, Liu, Jing, Chen, Qianhui, Huang, Xuan, Huang, Kuiyuan, Liu, Hongyan, Zhu, Wei, Zhang, Xiaoyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418329/ https://www.ncbi.nlm.nih.gov/pubmed/34490100 http://dx.doi.org/10.3389/fonc.2021.700700

Ejemplares similares

Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma
por: Chen, Qianhui, et al.
Publicado: (2022)

Aberrant Expression of PAFAH1B3 Affects Proliferation and Apoptosis in Osteosarcoma
por: Fan, Jian, et al.
Publicado: (2021)

PAFAH1B3 Expression Is Correlated With Gastric Cancer Cell Proliferation and Immune Infiltration
por: Xie, Tianyu, et al.
Publicado: (2021)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
por: Tang, Suping, et al.
Publicado: (2022)

CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates
por: Nie, Yuan, et al.
Publicado: (2021)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

The Pafah1b Complex Interacts with the Reelin Receptor VLDLR
por: Zhang, Guangcheng, et al.
Publicado: (2007)

Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma
por: Xiao, Jingjing, et al.
Publicado: (2022)

Identification of LSM family members as potential chemoresistance predictive and therapeutic biomarkers for gastric cancer
por: Liu, Qianhui, et al.
Publicado: (2023)

HIGD2A silencing impairs hepatocellular carcinoma growth via inhibiting mitochondrial function and the MAPK/ERK pathway
por: Huang, Kuiyuan, et al.
Publicado: (2023)

Aberrant expression of PAFAH1B3 associates with poor prognosis and affects proliferation and aggressiveness in hypopharyngeal squamous cell carcinoma
por: Xu, Jianing, et al.
Publicado: (2019)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

The phospholipase complex PAFAH Ib regulates the functional organization of the Golgi complex
por: Bechler, Marie E., et al.
Publicado: (2010)

Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma
por: Elmas, Abdulkadir, et al.
Publicado: (2022)

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
por: Xia, Haoming, et al.
Publicado: (2022)

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients
por: Jia, Bin, et al.
Publicado: (2023)

Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach
por: Fei, Xiaobin, et al.
Publicado: (2022)

Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma
por: Zhu, Zhipeng, et al.
Publicado: (2021)

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Tian-Hao, et al.
Publicado: (2021)

Transcriptomic identification of HBx-associated hub genes in hepatocellular carcinoma
por: Ni, Zhengzhong, et al.
Publicado: (2021)

Prognosis and therapeutic benefits prediction based on NK cell marker genes through single-cell RNA-seq with integrated bulk RNA-seq analysis for hepatocellular carcinoma
por: Yang, Yao, et al.
Publicado: (2023)

Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma
por: Xia, Haoming, et al.
Publicado: (2021)

CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2019)

The Landscape of Immune Cells Indicates Prognosis and Applicability of Checkpoint Therapy in Hepatocellular Carcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

A novel nomogram based on GD for predicting prognosis in hepatocellular carcinoma
por: Liu, Ying, et al.
Publicado: (2023)

Comprehensive Analysis of the Prognostic and Immunological Role of PAFAH1B in Pan-Cancer
por: Yuan, Yixiao, et al.
Publicado: (2022)

Interplay Between Non-Canonical NF-κB Signaling and Hepatitis B Virus Infection
por: Lu, Xinyu, et al.
Publicado: (2021)

Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma
por: Huang, Guang-zhao, et al.
Publicado: (2019)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
por: Shen, Chong, et al.
Publicado: (2022)

Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma
por: Liao, Rui, et al.
Publicado: (2021)

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma
por: Gao, Ying-jie, et al.
Publicado: (2023)

Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis
por: Zhu, Weihua, et al.
Publicado: (2021)

A macropinocytosis-related gene signature predicts the prognosis and immune microenvironment in hepatocellular carcinoma
por: Ding, Xinjiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v3oa62kt0jntae8tecc90comqr